Lung Cancer Research Program
Funds research to improve lung cancer prevention, detection, treatment, and survivorship, especially for military and Veteran populations, with emphasis on clinical relevance and innovative science.
Funder: Military Health System Research Program
Due Dates (Anticipated): May 2026 (LOI, Patient-Centered Outcomes and Survivorship Award) | June 2026 (Pre-proposal, all mechanisms) | September 2026 (Full application, invitation only)
Funding Amounts: Up to $800,000 (Idea Development, 3 yrs) | Up to $1.35M–$1.85M (Translational, 3–4 yrs) | Up to $975,000 (Patient-Centered Outcomes, 3 yrs); all amounts total costs.
Summary: Supports innovative, high-impact research to improve lung cancer prevention, detection, treatment, and survivorship, with a focus on military and Veteran populations.
Key Information: Submission requires pre-proposal (or LOI for Patient-Centered Outcomes); invitation needed for full application.
Description
The Lung Cancer Research Program (LCRP), administered by the Congressionally Directed Medical Research Programs (CDMRP), funds research aimed at eradicating deaths and suffering from lung cancer. The program targets projects that advance understanding of lung cancer biology, prevention, detection, treatment, and survivorship, with a strong emphasis on clinical relevance and direct benefit to Service Members, Veterans, and the general public. LCRP encourages studies that utilize military or Veteran populations, biospecimens, or data, and those that address unique exposures or health challenges faced by these groups. Multiple award mechanisms are available, supporting early-stage ideas, translational research, and patient-centered outcomes.
